356 related articles for article (PubMed ID: 31958465)
1. MFGE8 attenuates Ang-II-induced atrial fibrosis and vulnerability to atrial fibrillation through inhibition of TGF-β1/Smad2/3 pathway.
Ge Z; Chen Y; Wang B; Zhang X; Yan Y; Zhou L; Zhang Y; Xie Y
J Mol Cell Cardiol; 2020 Feb; 139():164-175. PubMed ID: 31958465
[TBL] [Abstract][Full Text] [Related]
2. MFGE8 is down-regulated in cardiac fibrosis and attenuates endothelial-mesenchymal transition through Smad2/3-Snail signalling pathway.
Wang B; Ge Z; Wu Y; Zha Y; Zhang X; Yan Y; Xie Y
J Cell Mol Med; 2020 Nov; 24(21):12799-12812. PubMed ID: 32945126
[TBL] [Abstract][Full Text] [Related]
3. LncRNA PVT1 regulates atrial fibrosis via miR-128-3p-SP1-TGF-β1-Smad axis in atrial fibrillation.
Cao F; Li Z; Ding WM; Yan L; Zhao QY
Mol Med; 2019 Mar; 25(1):7. PubMed ID: 30894138
[TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNA LICPAR regulates atrial fibrosis via TGF-β/Smad pathway in atrial fibrillation.
Wang H; Song T; Zhao Y; Zhao J; Wang X; Fu X
Tissue Cell; 2020 Dec; 67():101440. PubMed ID: 32971457
[TBL] [Abstract][Full Text] [Related]
5. The crucial role of activin A/ALK4 pathway in the pathogenesis of Ang-II-induced atrial fibrosis and vulnerability to atrial fibrillation.
Wang Q; Yu Y; Zhang P; Chen Y; Li C; Chen J; Wang Y; Li Y
Basic Res Cardiol; 2017 Jul; 112(4):47. PubMed ID: 28639003
[TBL] [Abstract][Full Text] [Related]
6. Atrial fibrillation induces myocardial fibrosis through angiotensin II type 1 receptor-specific Arkadia-mediated downregulation of Smad7.
He X; Gao X; Peng L; Wang S; Zhu Y; Ma H; Lin J; Duan DD
Circ Res; 2011 Jan; 108(2):164-75. PubMed ID: 21127293
[TBL] [Abstract][Full Text] [Related]
7. Upregulation of Transient Receptor Potential Canonical Type 3 Channel via AT1R/TGF-
He R; Zhang J; Luo D; Yu Y; Chen T; Yang Y; Yu F; Li M
Oxid Med Cell Longev; 2019; 2019():4025496. PubMed ID: 31871548
[TBL] [Abstract][Full Text] [Related]
8. MFGE8/Integrin β3 pathway alleviates apoptosis and inflammation in early brain injury after subarachnoid hemorrhage in rats.
Liu F; Chen Y; Hu Q; Li B; Tang J; He Y; Guo Z; Feng H; Tang J; Zhang JH
Exp Neurol; 2015 Oct; 272():120-7. PubMed ID: 25936875
[TBL] [Abstract][Full Text] [Related]
9. Increased α-Actinin-2 Expression in the Atrial Myocardium of Patients with Atrial Fibrillation Related to Rheumatic Heart Disease.
Zhang L; Zhang N; Tang X; Liu F; Luo S; Xiao H
Cardiology; 2016; 135(3):151-159. PubMed ID: 27344599
[TBL] [Abstract][Full Text] [Related]
10. Potential role of MG53 in the regulation of transforming-growth-factor-β1-induced atrial fibrosis and vulnerability to atrial fibrillation.
Guo J; Jia F; Jiang Y; Li Q; Yang Y; Xiao M; Xiao H
Exp Cell Res; 2018 Jan; 362(2):436-443. PubMed ID: 29233682
[TBL] [Abstract][Full Text] [Related]
11. Platelets Promote Ang II (Angiotensin II)-Induced Atrial Fibrillation by Releasing TGF-β1 (Transforming Growth Factor-β1) and Interacting With Fibroblasts.
Liu Y; Lv H; Tan R; An X; Niu XH; Liu YJ; Yang X; Yin X; Xia YL
Hypertension; 2020 Dec; 76(6):1856-1867. PubMed ID: 33175633
[TBL] [Abstract][Full Text] [Related]
12. Galectin-3 Induces Atrial Fibrosis by Activating the TGF-β1/Smad Pathway in Patients with Atrial Fibrillation.
Xiao M; Zhang M; Bie M; Wang X; Guo J; Xiao H
Cardiology; 2020; 145(7):446-455. PubMed ID: 32516780
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin II upregulates Kv1.5 expression through ROS-dependent transforming growth factor-beta1 and extracellular signal-regulated kinase 1/2 signalings in neonatal rat atrial myocytes.
Lu G; Xu S; Peng L; Huang Z; Wang Y; Gao X
Biochem Biophys Res Commun; 2014 Nov; 454(3):410-6. PubMed ID: 25451261
[TBL] [Abstract][Full Text] [Related]
14. Modulation of miR-10a-mediated TGF-β1/Smads signaling affects atrial fibrillation-induced cardiac fibrosis and cardiac fibroblast proliferation.
Li PF; He RH; Shi SB; Li R; Wang QT; Rao GT; Yang B
Biosci Rep; 2019 Feb; 39(2):. PubMed ID: 30683806
[TBL] [Abstract][Full Text] [Related]
15. PU.1 inhibition attenuates atrial fibrosis and atrial fibrillation vulnerability induced by angiotensin-II by reducing TGF-β1/Smads pathway activation.
Hu J; Zhang JJ; Li L; Wang SL; Yang HT; Fan XW; Zhang LM; Hu GL; Fu HX; Song WF; Yan LJ; Liu JJ; Wu JT; Kong B
J Cell Mol Med; 2021 Jul; 25(14):6746-6759. PubMed ID: 34132026
[TBL] [Abstract][Full Text] [Related]
16. Effect of Sox9 on TGF-β1-mediated atrial fibrosis.
Wang H; Chen Y; Zhao S; Wang X; Lu K; Xiao H
Acta Biochim Biophys Sin (Shanghai); 2021 Nov; 53(11):1450-1458. PubMed ID: 34596216
[TBL] [Abstract][Full Text] [Related]
17. MG53/CAV1 regulates transforming growth factor-β1 signaling-induced atrial fibrosis in atrial fibrillation.
Zhang M; Wang H; Wang X; Bie M; Lu K; Xiao H
Cell Cycle; 2020 Oct; 19(20):2734-2744. PubMed ID: 33000676
[TBL] [Abstract][Full Text] [Related]
18. LOXL2 Inhibitor Attenuates Angiotensin II-Induced Atrial Fibrosis and Vulnerability to Atrial Fibrillation through Inhibition of Transforming Growth Factor Beta-1 Smad2/3 Pathway.
Wu Y; Can J; Hao S; Qiang X; Ning Z
Cerebrovasc Dis; 2022; 51(2):188-198. PubMed ID: 34515064
[TBL] [Abstract][Full Text] [Related]
19. Role of caveolin-1 in atrial fibrillation as an anti-fibrotic signaling molecule in human atrial fibroblasts.
Yi SL; Liu XJ; Zhong JQ; Zhang Y
PLoS One; 2014; 9(1):e85144. PubMed ID: 24454806
[TBL] [Abstract][Full Text] [Related]
20. Beneficial effects of pioglitazone on atrial structural and electrical remodeling in vitro cellular models.
Gu J; Liu X; Wang QX; Guo M; Liu F; Song ZP; Zhang DD
J Mol Cell Cardiol; 2013 Dec; 65():1-8. PubMed ID: 24100253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
